DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NV-5138
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Treatment-Resistant
Unknown
NV-5138
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C7H13F2NO2
Molecular Weight:
181.18
AlogP:
1.08
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HM-71224
1
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Tyrosine-protein kinase BTK inhibitor
HM-71224
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MHAB5553A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MHAB5553A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ILS-920
1
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Unknown
ILS-920
×
Maximum Phase:
1
First Approval:
None
UNII:
F2D5P81X82
Molecule Type:
Small molecule
Molecular Formula:
C58H88N2O14
Molecular Weight:
1037.34
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SC-006
1
Unknown
Investigational
Unknown
Unknown
Colorectal Neoplasms
Unknown
SC-006
×
Maximum Phase:
1
First Approval:
None
UNII:
293BGU7HL8
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
WP 1066
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
WP 1066
×
Maximum Phase:
1
First Approval:
None
UNII:
63V8AIE65T
Molecule Type:
Small molecule
Molecular Formula:
C17H14BrN3O
Molecular Weight:
356.22
AlogP:
3.63
PSA:
65.78
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BDTX189
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 negative allosteric modulator
BDTX189
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H29ClN6O4
Molecular Weight:
561.04
AlogP:
4.84
PSA:
110.73
HBD:
2.0
HBA:
#RotB:
11.0
Source:
EPZ-5676
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPZ-5676
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RX-518
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RX-518
×
Maximum Phase:
1
First Approval:
None
UNII:
708TLB8J3Y
Molecule Type:
Small molecule
Molecular Formula:
C29H28F2N6O2
Molecular Weight:
530.58
AlogP:
4.56
PSA:
93.62
HBD:
3.0
HBA:
#RotB:
8.0
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
RO6958688
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RO6958688
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
INCAGN-02385
1
Unknown
Investigational
Unknown
Unknown
Melanoma
Unknown
INCAGN-02385
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0A08C63DF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZD-7648
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD-7648
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIUM IN 111 ALTUMOMAB PENTETATE
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
INDIUM IN 111 ALTUMOMAB PENTETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986258
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-986258
×
Maximum Phase:
1
First Approval:
None
UNII:
P339Q7RL7K
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NP-015
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NP-015
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SIBOFIMLOC
1
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
Unknown
SIBOFIMLOC
×
Maximum Phase:
1
First Approval:
None
UNII:
00OF00QZC4
Molecule Type:
Small molecule
Molecular Formula:
C35H39NO11
Molecular Weight:
649.69
AlogP:
-2.02
PSA:
200.61
HBD:
8.0
HBA:
#RotB:
2.0
Source:
N-HYDROXY-NOR-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
N-HYDROXY-NOR-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
SOBI-003
1
Unknown
Investigational
Unknown
Unknown
Mucopolysaccharidosis III
Unknown
SOBI-003
×
Maximum Phase:
1
First Approval:
None
UNII:
ZS87P77DQC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SECLIDEMSTAT
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Sarcoma, Ewing
Unknown
SECLIDEMSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
TYH386V3WJ
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClN4O4S
Molecular Weight:
450.95
AlogP:
2.14
PSA:
102.31
HBD:
2.0
HBA:
#RotB:
5.0
Source:
1
2
…
79
80
81
82
83
84
85
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA